On the contrary, in the presence of concordant BM, a noncanonical mutation in CALR, JAK2, or MPL and/or nondriver additional mutations detected through NGS can help to make a definitive diagnosis of ET and can help provide information on the patient’s prognosis (see below). This evidence concerns the gene CALR and essential thrombocythemia.